Observational Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Nov 28, 2016; 22(44): 9844-9852
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9844
Table 1 General and biochemical parameters of chronic hepatitis B and Non-alcoholic fatty liver disease patients
ParametersGroup
Control (n = 37)CHB (n = 26)NAFLD (n = 48)
General parameters
Age (yr)43.8 ± 1.340.1 ± 2.738.1 ± 1.8
Male n (%)18 (48.6)16 (61.5)35 (72.9)
BMI (kg/m2)21.4 ± 0.323.0 ± 0.6126.9 ± 0.512
Biochemical parameters
ALT (U/L)19.1 ± 2.4138.2 ± 30.8168.7 ± 7.412
GGT (U/L)19.1 ± 1.983.8 ± 16.7110.5 ± 35.9
TC (mmol/L)4.5 ± 0.14.5 ± 0.24.9 ± 0.1
TG (mmol/L)0.8 ± 0.11.7 ± 0.212.1 ± 0.21
HDL (mmol/L)1.4 ± 0.01.1 ± 0.111.2 ± 0.01
LDL (mmol/L)2.4 ± 0.12.5 ± 0.12.9 ± 0.112
Table 2 General and biochemical parameters of non-alcoholic fatty liver and non-alcoholic steatohepatitis patients
ParametersGroup
Control (n = 37)NAFL (n = 17)NASH (n = 31)
General parameters
Age (yr)43.8 ± 1.337.1 ± 3.138.1 ± 2.3
Male n (%)18 (48.6)13 (76.4)22 (71.0)
BMI (kg/m2)21.4 ± 0.326.3 ± 0.9127.2 ± 0.61
Biochemical parameters
ALT (U/L)19.1 ± 2.447.8 ± 6.2180.2 ± 10.412
AST (U/L)18.8 ± 1.430.2 ± 3.851.5 ± 6.012
GGT (U/L)19.1 ± 1.978.2 ± 36.8128.2 ± 51.9
PLT (× 109/L)200.4 ± 11.3237.0 ± 14.8207.3 ± 9.1
TC (mmol/L)4.5 ± 0.14.7 ± 0.25.0 ± 0.1
TG (mmol/L)0.8 ± 0.11.9 ± 0.312.2 ± 0.31
HDL (mmol/L)1.4 ± 0.01.2 ± 0.111.2 ± 0.11
LDL (mmol/L)2.4 ± 0.12.9 ± 0.212.9 ± 0.11
Table 3 Correlations between miRNAs and histological features
RmiR-122miR-125bmiR-146bmiR-16miR-192miR-21miR-27bmiR-34a
Steatosis0.30210.1430.2300.0680.32310.1990.1660.4702
Activity0.44520.0520.2180.2670.44720.32010.1790.5172
Lobular inflammation0.2851-0.0640.1370.1590.39620.2540.1840.5522
Hepatocellular ballooning0.47720.1540.2250.29010.35010.2810.1010.3171
Fibrosis-0.021-0.0780.1250.35010.1450.199-0.0280.134